Study: New melanoma drug doubles survival time
from CBS News
Advanced melanoma is often considered a death sentence, since patients will live only 6 to 10 months by the time it's diagnosed. A new study of a recently approved drug called vemurafenib offers hope, because it nearly doubled life expectancy of patients with metastatic melanoma to 16 months.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063